Herpes Zoster
Real-world data trumpet effectiveness of recombinant zoster vaccine
Real-world data reported in Clinical Infectious Diseases demonstrated that the recombinant zoster vaccine was more than 85% effective at preventing herpes zoster.
Herpes zoster more common with upadacitinib than adalimumab plus methotrexate in RA
Among patients with rheumatoid arthritis, herpes zoster is more common in those treated with upadacitinib than with adalimumab plus methotrexate or with methotrexate alone, according to a speaker at ACR Convergence 2020.
Adult vaccination coverage, compliance varies widely by state
Adult vaccination coverage and compliance varies substantially by state, even with adjustments for individual state-characteristics, according to study results presented at IDWeek.
Recombinant zoster vaccine reduces HZ-related pain, use of pain medication
The recombinant zoster vaccine not only effectively prevents herpes zoster, it reduces herpes-zoster-related pain and the use of pain medication, according to data presented at IDWeek.
Baricitinib increased overall infection risk in patients with RA
Baricitinib was linked to increased rates of overall infections, including herpes zoster, among patients with rheumatoid arthritis but did not impact incidence of serious infections, researchers noted in the Annals of the Rheumatic Diseases.
Inflammatory skin diseases may be associated with herpes zoster hospitalization risk
Shingrix induces persistent immune responses in older adults, regardless of Zostavax dose
Two doses of the recombinant herpes zoster vaccine Shingrix induced “strong and persistent” immune responses in older adults, irrespective of whether they previously received the live-attenuated herpes zoster vaccine, Zostavax, according to results from a study published in The Journal of Infectious Diseases.
Top news from February: Coronavirus complications, women’s heart health and more
Healio and Cardiology Today have compiled a list of the most-read news published in February.
Type of shingles vaccine cuts stroke risk by 16% in elderly
A type of herpes zoster vaccine reduced risk for stroke in Medicare beneficiaries aged at least 66 years, according to findings presented at the International Stroke Conference.
Tofacitinib linked to 2-fold greater risk for herpes zoster in RA
Among patients with rheumatoid arthritis, tofacitinib is associated with a 2-fold greater risk for herpes zoster infection compared with etanercept, abatacept, adalimumab, golimumab, certolizumab, infliximab and tocilizumab, according to data published in The Lancet Rheumatology.